Homozygous CD11c-IL-17Aind/ind mice and heterozygous CD11c-IL-17A ind/+ mice show a delayed onset of moderate to severe psoriasis-like skin disease associated with reduced amounts of cutaneous IL-17A compared with K14-IL-17Aind/+ mice. Here, IL17A is linked to psoriasis.